Andreas Castan is an R&D scientist for GE Healthcare’s Life Sciences business. In this role, Andreas provides leadership and support to the Bioprocess business. His main area of expertise is in upstream processing.

Prior to joining GE Healthcare, Andreas was Director Upstream Development at Swedish Orphan Biovitrum AB, working with development of expression systems, process development of microbial and mammalian cell-based processes, and scale-up to cGMP manufacturing scales. During the last 20 years, Andreas has held several positions within biopharmaceutical development, including project and line management as well as manufacturing.

Andreas studied chemical engineering at the Technische Universität Hamburg (TUHH), Germany. He received a Ph.D. in Biochemical Engineering at the Royal Institute of Technology (KTH), Stockholm.